At its April board meeting, Manor College introduced Leonard Mazur as the new Board of Trustees Chairman. Mazur’s affiliation and support of Manor College dates back some 40 years to 1971 when he joined the college as a member of the Council of President’s Advisors, a position he held until 1979.
Mazur joined the Board of Trustees in 2000 and was elected to his new role as Chairman in 2013. In 2009, Mazur was presented with the Manor College Community Leadership Award at the college’s annual Spring Gala fundraising event. Mazur served as Chair of the Board’s Standing Committee on Institutional Planning in 2010 and in 2012 he was the Chair of Board’s Standing Committee on Development and Alumni Relations.
Mazur commented that he has remained supportive of Manor College and its mission for so long because he has always been, “impressed with the dedication and commitment that the administration and the faculty have toward the students.
“Manor really goes the extra mile to make sure that each student have every opportunity possible to complete his or her program,” he said.
As the new chairman of the Board of Trustees, Mazur said he intends to, “work hand in hand with the administration to ensure that the strategic plan and the vision for the school are executed appropriately.
“I think I can contribute to that process,” he said.
“Leonard is and has been a significant partner in the growth of the mission of Manor College, said College President Sister Mary Cecilia Jurasinski, OSBM. “As the new Board Chair, his leadership will challenge the Manor College community to reach for new heights of excellence and serevice.”
Mazur’s accomplishments as an entrepreneur and a supporter of the Ukrainian community are impressive. He has been instrumental in creating enterprises within companies and as a founder of numerous pharmaceutical companies.
He began his business career with Cooper Laboratories while completing his master’s in business administration. During his ten year career at Cooper, Mazur advanced from a sales representative position to a series of marketing, strategic planning, corporate development, and general management positions which included operating responsibilities for a division of the company. Notably, while at Cooper, he was involved in the creation of Cooper Vision, which ultimately became the largest eye care company in the United States.
In 1981, Mazur joined the U.S. Pharmaceutical Division of BASF as director of marketing. He was responsible for introducing into the U.S. market one of the first calcium channel blockers, a breakthrough medication used to treat hypertension and other heart disorders. He then joined, in 1984, ICN Pharmaceuticals as vice president of sales and marketing. While at ICN, he launched the first antiviral drug for treatment of a deadly respiratory virus that afflicts infants.
After ICN, Mazur was selected by the board of directors at Chantal Pharmaceuticals, a research-based company, to restructure its operations; a task which he completed within 18 months. In 1989, he joined Medicis Pharmaceuticals as a member of the founding executive team. As executive vice president, he was instrumental in establishing a dermatology-oriented company that has become a leader within its industry niche.
In 1995, he founded Genesis Pharmaceutical, which is a company focused on dermatological products. Genesis was ultimately acquired by Pierre Fabre Group, based in France. Following Genesis, he established Triax Pharmaceuticals, which became a top ten company in the prescription dermatological market and was ultimately acquired by Precision Dermatologicals. Presently, Mazur is vice chairman and co-founder of Akrimax Pharmaceuticals, a cardiovascular pharmaceutical company he created in 2008. He serves as a board member of several new pharmaceutical ventures.
Mazur was born in Germany and as a young boy immigrated to the US with his parents and is active in various Ukrainian –American organizations. He is a member of the Board for the Children of Chernobyl Relief Fund and in 1991 was a member of the US Independent Observer Team for Referendum for the Independence of Ukraine.
Mazur holds both a Bachelor of Arts and an MBA from Temple University. He has been awarded a US patent for a cholesterol lowering drug and is the recipient of the Ellis Island Medal of Honor and Temple University’s Diamond Achievement Award.
Manor College President Sister Mary Cecilia Jurasinski, OSBM (right) and Sally Mydlowec, executive vice president and dean of Academic Affairs (left) meet with new Board of Trustees Chairman Leonard Mazur (center).